BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24516197)

  • 1. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.
    Chung JS; Tamura K; Akiyoshi H; Cruz PD; Ariizumi K
    J Immunol; 2014 Mar; 192(6):2576-84. PubMed ID: 24516197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.
    Chung JS; Tamura K; Cruz PD; Ariizumi K
    J Invest Dermatol; 2014 Nov; 134(11):2784-2794. PubMed ID: 24936834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation.
    Chung JS; Dougherty I; Cruz PD; Ariizumi K
    J Immunol; 2007 Nov; 179(9):5778-84. PubMed ID: 17947650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depleting syndecan-4+ T lymphocytes using toxin-bearing dendritic cell-associated heparan sulfate proteoglycan-dependent integrin ligand: a new opportunity for treating activated T cell-driven disease.
    Akiyoshi H; Chung JS; Tomihari M; Cruz PD; Ariizumi K
    J Immunol; 2010 Apr; 184(7):3554-61. PubMed ID: 20176742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
    Wu F; Dang D; Guo J; Li H; Yang K; Zhao D; Guo P; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):789-92, 797. PubMed ID: 25108427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM; Esmon NL; Esmon CT; Bynoe MS
    J Immunol; 2013 Oct; 191(7):3764-77. PubMed ID: 23997223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
    J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H; Guo C; Yu X; Zuo D; Wang XY
    J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b
    Arellano G; Acuña E; Loda E; Moore L; Tichauer JE; Castillo C; Vergara F; Burgos PI; Penaloza-MacMaster P; Miller SD; Naves R
    J Neuroinflammation; 2024 May; 21(1):144. PubMed ID: 38822334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.
    Chung JS; Tomihari M; Tamura K; Kojima T; Cruz PD; Ariizumi K
    Immunology; 2013 Feb; 138(2):173-82. PubMed ID: 23113638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the
    Kobayashi M; Chung JS; Beg M; Arriaga Y; Verma U; Courtney K; Mansour J; Haley B; Khan S; Horiuchi Y; Ramani V; Harker D; Gopal P; Araghizadeh F; Cruz PD; Ariizumi K
    Clin Cancer Res; 2019 Jan; 25(2):828-838. PubMed ID: 30049749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of DC-HIL to dermatophytic fungi induces tyrosine phosphorylation and potentiates antigen presenting cell function.
    Chung JS; Yudate T; Tomihari M; Akiyoshi H; Cruz PD; Ariizumi K
    J Immunol; 2009 Oct; 183(8):5190-8. PubMed ID: 19794069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses.
    Chung JS; Bonkobara M; Tomihari M; Cruz PD; Ariizumi K
    Eur J Immunol; 2009 Apr; 39(4):965-74. PubMed ID: 19350579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.
    Garcia JA; Pino PA; Mizutani M; Cardona SM; Charo IF; Ransohoff RM; Forsthuber TG; Cardona AE
    J Immunol; 2013 Aug; 191(3):1063-72. PubMed ID: 23817416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells.
    Tomihari M; Chung JS; Akiyoshi H; Cruz PD; Ariizumi K
    Cancer Res; 2010 Jul; 70(14):5778-87. PubMed ID: 20570888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury.
    Diao W; Jin F; Wang B; Zhang CY; Chen J; Zen K; Li L
    Protein Cell; 2014 Sep; 5(9):714-24. PubMed ID: 24981055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b
    Zhu J; Liu JQ; Liu Z; Wu L; Shi M; Zhang J; Davis JP; Bai XF
    Front Immunol; 2018; 9():873. PubMed ID: 29740452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
    Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
    Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
    Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
    Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.